Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Salzman

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
International Journal of Geriatric Psychiatry|April 21, 2007
Are there predictors of outcome in depressed elderly nursing home residents during treatment with mirtazapine orally disintegrating tablets?J Craig Nelson, Karen Holden, Steven Roose, et al.
Psychiatric Services (Washington, D.C.)|July 10, 2003
Lack of relationship between long-term use of benzodiazepines and escalation to high dosagesStephen B Soumerai, Linda Simoni-Wastila, Cara Singer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 20, 2007
ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementiaDilip V Jeste, Dan Blazer, Daniel Casey, et al.
Psychiatric Services (Washington, D.C.)|February 3, 2011
Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorderChristine Y Lu, Alyce S Adams, Dennis Ross-Degnan, et al.
Journal of Clinical Psychopharmacology|January 22, 2008
Teaching psychopharmacology: what works and what doesn'tSidney Zisook, Ira D Glick, James W Jefferson, et al.
The American Journal of Psychiatry|August 6, 2003
Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?Steven E Bruce, Russell G Vasile, Robert M Goisman, et al.
The Journal of Clinical Psychiatry|May 30, 2024
Concerns About Long-Term Benzodiazepine Treatment and the State of the Evidence: Reply to Sigler et alEdward Silberman, Antonio E Nardi, Vladan Starcevic, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 12, 2020
Benzodiazepines: it's time to return to the evidenceEdward Silberman, Richard Balon, Vladan Starcevic, et al.
The Journal of Clinical Psychiatry|October 26, 2023
Resolving the Paradox of Long-Term Benzodiazepine Treatment: Toward Evidence-Based Practice GuidelinesEdward Silberman, Antonio E Nardi, Vladan Starcevic, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|May 15, 2007
Improving the pedagogy associated with the teaching of psychopharmacologyIra D Glick, Carl Salzman, Bruce M Cohen, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
International Journal of Geriatric Psychiatry|April 21, 2007
Are there predictors of outcome in depressed elderly nursing home residents during treatment with mirtazapine orally disintegrating tablets?J Craig Nelson, Karen Holden, Steven Roose, et al.
Psychiatric Services (Washington, D.C.)|July 10, 2003
Lack of relationship between long-term use of benzodiazepines and escalation to high dosagesStephen B Soumerai, Linda Simoni-Wastila, Cara Singer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 20, 2007
ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementiaDilip V Jeste, Dan Blazer, Daniel Casey, et al.
Psychiatric Services (Washington, D.C.)|February 3, 2011
Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorderChristine Y Lu, Alyce S Adams, Dennis Ross-Degnan, et al.
Journal of Clinical Psychopharmacology|January 22, 2008
Teaching psychopharmacology: what works and what doesn'tSidney Zisook, Ira D Glick, James W Jefferson, et al.
The American Journal of Psychiatry|August 6, 2003
Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?Steven E Bruce, Russell G Vasile, Robert M Goisman, et al.
The Journal of Clinical Psychiatry|May 30, 2024
Concerns About Long-Term Benzodiazepine Treatment and the State of the Evidence: Reply to Sigler et alEdward Silberman, Antonio E Nardi, Vladan Starcevic, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 12, 2020
Benzodiazepines: it's time to return to the evidenceEdward Silberman, Richard Balon, Vladan Starcevic, et al.
The Journal of Clinical Psychiatry|October 26, 2023
Resolving the Paradox of Long-Term Benzodiazepine Treatment: Toward Evidence-Based Practice GuidelinesEdward Silberman, Antonio E Nardi, Vladan Starcevic, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|May 15, 2007
Improving the pedagogy associated with the teaching of psychopharmacologyIra D Glick, Carl Salzman, Bruce M Cohen, et al.
Pageof 7